Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C)
Central European Journal of Immunology · 30.05.2022 · 47 (2) · 151-159
DOI: 10.5114/ceji.2022.116385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Central European Journal of Immunology, online erschienen am 30.05.2022. Verfasst von Ewelina Gowin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Promotion Department, Poznan University of Medical Sciences, Poland. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
The pathophysiology of multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C) remains poorly understood. This study aimed to define peripheral blood immune features in patients with MIS-C. Material and methods We analyzed seven children diagnosed with MIS-C between April 1 and May 15, 2021, in St. Joseph’s Children’s Hospital in Poznan (Poland).
Results
All patients had elevated inflammatory markers, IgG antibodies against SARS-CoV-2, and lymphopenia with a marked decrease in CD4+ and CD8+ T cells. The majority of CD4+ T cells were naive cells. Almost all (6/7) of the analyzed patients had a higher CD4+/CD8+ T cell ratio than average values. B cells were within the normal range – the majority were non-memory cells.
Conclusions
Children with MIS-C do not resemble adults during COVID-19 recovery. The immune profile of the studied patients differs from that of children with Kawasaki disease (KD), but it is similar to that of adults with severe COVID-19. The proposed explanation is a profound lymphopenia caused by SARS-CoV-2 infection – which persists for weeks – as a result leading to uncontrolled inflammation. In COVID-19 patients the T cell level returns to normal after the second week of the disease. Our data suggest that in children prolonged lymphopenia after COVID-19 can be a practical marker for possible MIS-C alert. If there is a continuum from lymphopenia to MIS-C, there is room for screening and prevention. Further studies are needed to determine whether steroid treatment introduced in a child with prolonged lymphopenia could stop the inflammatory process.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Promotion Department, Poznan University of Medical Sciences, Poland.
- Department of Clinical Pathomorphology, Poznan University of Medical Sciences, Poland.
- Department of Oncology, Hematology, and Bone Marrow Transplantation, Poznan University of Medical Sciences, Poland.
Zitieren
APA
Gowin, E., Dworacki, G., Siewert, B., Wysocki, J., & Januszkiewicz-Lewandowska, D. (2022). Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C). Central European Journal of Immunology, 47(2), 151-159. https://doi.org/10.5114/ceji.2022.116385
Vancouver
Gowin E, Dworacki G, Siewert B, Wysocki J, Januszkiewicz-Lewandowska D. Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C). Central European Journal of Immunology. 2022;47(2):151-159. doi:10.5114/ceji.2022.116385
BibTeX
@article{Gowin2022,
author = {Gowin, Ewelina and Dworacki, Grzegorz and Siewert, Bartosz and Wysocki, Jacek and Januszkiewicz-Lewandowska, Danuta},
title = {Immune profile of children diagnosed with multisystem inflammatory syndrome associated with SARS-CoV-2 infection (MIS-C)},
journal = {Central European Journal of Immunology},
year = {2022},
volume = {47},
number = {2},
pages = {151--159},
doi = {10.5114/ceji.2022.116385}
}
EUVIMED